COBALT advises Acino shareholders on the sale of shares to ADQ

COBALT advises Acino’s current shareholders Nordic Capital and Avista Capital Partners on selling 100% of shares to ADQ, one of the biggest holding companies in Abu Dhabi.

Acino is a Swiss pharmaceutical company that delivers quality pharmaceuticals to promote affordable healthcare in emerging markets and leverages its high-quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out-licensing.

ADQ was established in Abu Dhabi in 2018 and is one of the region´s largest companies with direct and indirect investments in more than 90 companies locally and internationally.
ADQ investment broad portfolio includes energy and utilities, food and agriculture, healthcare and pharma, mobility, and logistics amongst others.

Our work comprises advising the client throughout the transaction as a local advisor. COBALT´s team consists of Partner Martin Simovart, Specialist Counsel Jesse Kivisaari, Associate Johanna-Britt Haabu, and Junior Associate Getter Villmann.

Read more: Acino press release